MWVC
BIIB icon

Morgens Waterfall Vintiadis & Co’s Biogen BIIB Stock Holding History

Morgens Waterfall Vintiadis & Co’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-7,800
Closed -$3.15M – 38
2015
Q2 		$3.15M Buy
+7,800
New +$3.13M 1.98% 23

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Morgens Waterfall Vintiadis & Co's BIIB Position: Q3 2015 in Review

Morgens Waterfall Vintiadis & Co sold out of Biogen (BIIB) in Q3 2015, closing a stake of 7,800 shares — an estimated $3.15M sold.

Morgens Waterfall Vintiadis & Co first reported a position in BIIB in Q2 2015 and held it in 1 quarter. The position peaked at $3.15M in Q2 2015. 924 funds tracked by Wall St. Rank hold BIIB as of Q3 2015.

  • Morgens Waterfall Vintiadis & Co reported no remaining Biogen position as of Q3 2015 after selling out during the quarter.
  • Morgens Waterfall Vintiadis & Co sold 7,800 Biogen shares in Q3 2015, an estimated $3.15M.
  • Morgens Waterfall Vintiadis & Co first reported a position in Biogen in Q2 2015 and held it in 1 quarter.
  • Morgens Waterfall Vintiadis & Co's Biogen position peaked at $3.15M in Q2 2015.
  • 924 funds tracked by Wall St. Rank held Biogen as of Q3 2015.

Based on Morgens Waterfall Vintiadis & Co's 13F filing for Q3 2015, filed 10 Nov 2015.